Dr. reddy's q2 & h1 fy21 financial results

Hyderabad, india--(business wire)--dr. reddy's laboratories ltd. (bse: 500124 | nse: drreddy | nyse: rdy) today announced its consolidated financial results for the quarter and the half year ended september 30, 2020. the information mentioned in this release is on the basis of consolidated financial statements under international financial reporting standards (ifrs). q2 performance summary h1 performance summary   rs. 4,897 cr rs. 9,314 cr revenue revenue [up: 11% qoq; 2% yoy] [up: 8% yoy]   53
RDY Ratings Summary
RDY Quant Ranking